Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Drug-induced liver disease.

¹Department of Medicine, Georgetown University School of Medicine, Washington, DC, USA.

The Medical Clinics of North America

|October 12, 2000

Summary

Drug-induced liver disease is rising with new medications. This review covers its incidence, diagnosis, risk factors, presentations, and injury patterns from common drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

McSART: an iterative model-based, motion-compensated SART algorithm for CBCT reconstruction.

Physics in medicine and biology·2019

Same author

A prospective gating method to acquire a diverse set of free-breathing CT images for model-based 4DCT.

Physics in medicine and biology·2018

Same author

SU-E-J-210: Lung Tumor Target Volume Contours on EPID Cine Mode Images.

Medical physics·2017

Same author

3D fluoroscopic image estimation using patient-specific 4DCBCT-based motion models.

Physics in medicine and biology·2015

Same author

Letter: antibiotic dose adjustment in patients with advanced liver disease--authors' reply.

Alimentary pharmacology & therapeutics·2013

Same author

Review article: prescribing medications in patients with cirrhosis - a practical guide.

Alimentary pharmacology & therapeutics·2013

Area of Science:

Hepatology
Clinical Pharmacology

Background:

The increasing introduction of novel pharmaceutical agents has coincided with a rise in drug-induced liver disease (DILD).
Understanding DILD is crucial due to its growing prevalence and potential for severe hepatic injury.

Purpose of the Study:

To provide a comprehensive overview of the current understanding of drug-induced liver disease.
To highlight recent developments, publications, and reports concerning DILD.

Main Methods:

Literature review of incidence, diagnosis, risk factors, and clinical presentations of DILD.
Analysis of hepatic injury patterns associated with commonly prescribed medications.
Focus on newer developments and recent publications in the field.

Main Results:

The incidence of DILD is increasing, linked to the expanding array of available drugs.
Key aspects discussed include hepatitis and vascular injury as manifestations of DILD.
The review emphasizes hepatic injury from frequently used drugs, incorporating recent findings.

Conclusions:

The rising incidence of DILD necessitates continued vigilance and research.
Accurate diagnosis, risk factor identification, and understanding of clinical presentations are vital.
Ongoing review of drug safety and hepatic injury patterns is essential for clinical practice.

Related Experiment Videos